|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | C07D 401/14 | (2006.01) |
| A61K 47/12 | (2006.01) | ||
| A61P 31/04 | (2006.01) |
| (11) | Number of the document | 3056492 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15199355.7 |
| Date of filing the European patent application | 2005-10-07 | |
| (97) | Date of publication of the European application | 2016-08-17 |
| (45) | Date of publication and mention of the grant of the patent | 2021-09-22 |
| (46) | Date of publication of the claims translation | 2022-01-25 |
| (30) | Number | Date | Country code |
| 617334 P | 2004-10-08 | US |
| (72) |
Zhang, Geoff, G. , US
Bradley, Michael, F. , US
Barnes, David, M. , US
Henry, Rodger , US
|
| (73) |
AbbVie Inc. ,
1 North Waukegan Road, North Chicago, IL 60064,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Meglumino druska ir atitinkamos vaisto (delafloksacino) kristalinės formos |
| MEGLUMINE SALT AND CRYSTALLINE FORMS THEREOF OF A DRUG (DELAFLOXACIN) |
| Payment date | Validity (years) | Amount | |
| 2024-09-13 | 347.00 EUR |